Modelling and simulation: questions and answers

Table of contents

The European Medicines Agency's (EMA) provides an overview of its position on specific issues related to modelling and simulation in the form of questions and answers (Q&As).

Users should read the Q&As in conjunction with the relevant scientific guidelines.

The Committee for Medicinal Products for Human Use (CHMP) and the Paediatric Committee (PDCO) may seek the input of the Methodology Working Party (MWP) to address specific questions in relation to modelling and simulation.

The date after each question refers to when it was first published.



How useful was this page?

Add your rating
17 ratings
3 ratings